ENDRA Life Sciences Inc.

NASDAQ: NDRA · Real-Time Price · USD
4.53
0.09 (2.03%)
At close: Aug 15, 2025, 10:00 AM

ENDRA Life Sciences Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.61 -629.86 -1.04K -4.43K
PEG Ratio
-0.01 -21.81 63.30 78.87
PS Ratio
n/a n/a n/a n/a
PB Ratio
2.74 1.12K 1.91K 4.59K
P/FCF Ratio
-0.95 -661.25 -1.06K -4.44K
P/OCF Ratio
-0.95 -663.6 -1.08K -4.45K
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.23 0.07 0.08 0.06
Quick Ratio
5.67 3.36 3.45 7.00
Current Ratio
5.67 3.36 5.00 7.83
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
n/a n/a -611.04 n/a
Return on Equity
-4.49 -1.78 -1.83 -1.04
Return on Assets
-2.58 -1.49 -1.42 -0.87
Return on Invested Capital
-4.6 -1.74 -1.7 -0.99
Dividend Yield
0.00 0.00 0.00 0.00
Payout Ratio
-0.00 -0.00 -0.00 -0.01
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a